A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911
QL0911-102
Phase 1 other active
Quick answer
A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911 for Immune Thrombocytopenia, Hematopoietic Syndrome of Acute Radiation Syndrome is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Immune Thrombocytopenia, Hematopoietic Syndrome of Acute Radiation Syndrome
- Phase
- Phase 1
- Modality
- other
- Status
- active